Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

46results about How to "Less consumption options" patented technology

Folic acid pellet and preparation method thereof

The invention provides a folic acid pellet preparation composed of folic acid and medical supplementary materials. The folic acid pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of folic acid is 0.02-20 percent by weight, the content of excipients is 75-99.98 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.
Owner:JF PHARMALAND TECH DEV

Sanchi extract pellets and preparation method thereof

InactiveCN101703546AGood dispersionQuick effectNervous disorderAntipyreticPanax notoginseng extractDissolution
The invention provides sanchi extract pellets, which are prepared from a sanchi extract and medicinal accessories, and are characterized in that: the medicinal accessories comprise an excipient and a bonding agent; the sanchi extract accounts for 10 to 90 percent of the weight of the pellets; the excipient accounts for 4 to 89 percent of the weight of the pellets; and the bonding agent accounts for 1 to 6 percent of the weight of the pellets. The pellets can be made into a sustained-release or enteric-coated preparation. The sanchi extract pellets of the invention have high dissolution rate and high bioavailability. The method of the invention is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Zinc gluconate pellets and preparation method thereof

The invention provides a zinc gluconate pellet preparation, which is prepared from zinc gluconate and pharmaceutic adjuvant, and is characterized in that: the pharmaceutic adjuvant is an excipient and an adhesive, wherein in the pellet preparation, the weight percent of the zinc gluconate is 10 to 80 percent, the weight percent of the excipient is 12 to 89 percent and the weight percent of the adhesive is 1 to 8 percent. The pellet preparation can be prepared into a slow release preparation or an enteric-coated preparation. The zinc gluconate pellet preparation has high dissolution rate, and high bioavailability; and the method is simple, convenient, and easy to operate.
Owner:JF PHARMALAND TECH DEV

Desertliving cistanche herb extract pellet and preparation method thereof

The invention provides a desertliving cistanche herb extract pellet preparation composed of desertliving cistanche herb extract and medical supplementary materials. The desertliving cistanche herb extract pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of desertliving cistanche herb extract 1-80 percent by weight, the content of excipients is 20-99 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.
Owner:JF PHARMALAND TECH DEV

Propolis micropill and preparation method thereof

The invention provides a preparation of propolis micropill which is made of propolis and medical accessories and is characterized in that the medical accessories comprise excipient and bond. The preparation of the micropill is made of the following components by the weight percentage: 5-80 percent of propilis, 20-95 percent of excipient and 1-5 percent of bond. The preparation of the micropill has the advantages of high stripping rate and high bioavailability, and the preparation method is simple and convenient and can be operated easily.
Owner:JF PHARMALAND TECH DEV

Chondroitin sulfate pellet and preparation method thereof

The invention provides a chondroitin sulfate pellet preparation, which is prepared from chondroitin sulfate and pharmaceutic adjuvant. The pellet preparation is characterized in that the pharmaceutic adjuvant is excipient and bonding agent, wherein the pellet preparation comprises the following components in percentage by weight: 10 to 90 percent of the chondroitin sulfate, 3 to 89 percent of the excipient, and 1 to 7 percent of the bonding agent. The pellet preparation can be prepared into a slow-release preparation or an enteric-coated preparation as requested. The chondroitin sulfate pellet preparation has high dissolution rate and high bioavailability, and the method is simple and convenient and is easy to operate.
Owner:JF PHARMALAND TECH DEV

Astragalus polyose pellet and preparation method thereof

The invention provides an astragalus polyose pellet preparation composed of astragalus polyose and medical supplementary materials. The astragalus polyose pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of astragalus polyose 0.5-70 percent by weight, the content of excipients is 30-99.5 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.
Owner:JF PHARMALAND TECH DEV

Beta-carotene pellet and method for preparing the same

InactiveCN101219126AGood dispersionQuick effectOrganic active ingredientsAntinoxious agentsBeta-CaroteneAdjuvant
The invention provides a beta-carotene micro-pill prepared from beta-carotene and medicinal adjuvant, characterized in that the medicinal adjuvant comprises an excipient and a bonding agent; the content of the beta-carotene in the beta-carotene micro-pill is 1-10 weight percent, the excipient 70-95 weight percent and the bonding agent 1-5 weight percent. The beta-carotene micro-pill of the invention has the advantages of high dissolution rate, high bioavailability, easy preparation method and convenient and easy operation.
Owner:JF PHARMALAND TECH DEV

Donkey-hide gelatin micro-pills and preparation method thereof

The invention discloses a pellet formulation of donkey-hide gelatin which is prepared by donkey-hide gelatin and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the donkey-hide gelatin is 20-80 %, the weight percentage of the excipient is 20-80%, and the weight percentage of the adhesive is 1-5%. The pellet formulation can be made into sustained release formulation or enteric-coated formulation according to the requirements. The inventive pellet formulation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.
Owner:JF PHARMALAND TECH DEV

Soybean isoflavone micropills and preparation thereof

The present invention provides a soybean isoflavone pellet preparation which is made from the soybean isoflavone and medical auxiliary materials and is characterized in that the medical auxiliary materials are excipient and bond. In the pellet preparation, the weight percentages of the materials are that: 1 percent to 50 percent of the soybean isoflavone, 55 percent to 98 percent of the excipient and 1 percent to 5 percent of the bond. The pellet preparation can be made into a slow-release or intestinal juice soluble preparation according to the requirement. The pellet preparation of the present invention has high leaching rate and high biological utilization degree, and the preparation method is simple and convenient and is easy for operating.
Owner:JF PHARMALAND TECH DEV

Pearl powder micro-pills and preparation method thereof

The invention discloses a pellet formulation of pearl powder which is prepared by pearl powder and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the pearl powder is 5-80%, the weight percentage of the excipient is 20-95%, and the weight percentage of the adhesive is 1-5%. The inventive pellet formulation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.
Owner:JF PHARMALAND TECH DEV

Levorotation carnitine pellet and method for preparing the same

The invention provides a levocarnitine micro-pill which is prepared from levocarnitine and pharmaceutic adjuvant, characterized in that the pharmaceutic adjuvant is an excipient and a bonding agent; the content of the levocarnitine in the levocarnitine micro-pill is 10 to 90 weight percent; the excipient 20-80 weight percent and the bonding agent 1-5 weight percent. The levocarnitine micro-pill of the invention has the advantages of high dissolution rate, high bioavailability, easy preparation method and convenient and easy operation.
Owner:JF PHARMALAND TECH DEV

Sea cucumber peptide micro-pills and preparation method thereof

The invention discloses a pellet formulation of sea cucumber peptide which is prepared by sea cucumber peptide and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the sea cucumber peptide is 2-85%, the weight percentage of the excipient is 20-80%, and the weight percentage of the adhesive is 1-5%. The inventive pellet preparation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.
Owner:JF PHARMALAND TECH DEV

Compound hyaluronic acid pellet and preparation method thereof

InactiveCN104664399AGood dispersionQuick effectFood preparationBioavailabilityOrganic chemistry
The invention provides a compound hyaluronic acid pellet preparation. The compound hyaluronic acid pellet preparation is prepared from hyaluronic acid, VC and pharmaceutical accessories and is characterized in that the pharmaceutical accessories include an excipient and an adhesive; and the compound hyaluronic acid pellet preparation contains 5-20% by weight of hyaluronic acid, 1-5% by weight of VC, 70-85% by weight of the excipient and 1-5% by weight of the adhesive. The compound hyaluronic acid pellet preparation disclosed by the invention has high dissolution rate and bioavailability; and a preparation method is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Vitamin E micropill and preparation method thereof

The invention provides a preparation of a vitamin E micropill which is made of vitamin E and medical accessories and is characterized in that the medical accessories comprise excipient and bond. The preparation of the micropill is made of the following components by the weight percentage: 1-85 percent of vitamin E, 15-99 percent of excipient and 1-5 percent of bond. The preparation of the micropill has the advantages of high stripping rate and high bioavailability, and the preparation method is simple and convenient and can be operated easily.
Owner:JF PHARMALAND TECH DEV

Novel tea polyphenol spherical particles

InactiveCN105560603AGood dispersionQuick effectOrganic active ingredientsFood preparationMedicinePhenolic content in tea
The invention relates to novel tea polyphenol spherical particles, and provides a tea polyphenol micro-pellet preparation, which is prepared from tea polyphenol and pharmaceutical auxiliary materials, and is characterized in that the pharmaceutical auxiliary materials comprise an excipient and a binder, wherein the tea polyphenol content in the micro-pellet preparation is 5-30 wt%, the excipient content in the micro-pellet preparation is 75-90 wt%, and the binder content in the micro-pellet preparation is 1-5 wt%. According to the present invention, the micro-pellet preparation has characteristics of high bioavailability and high dissolution rate, and the preparation method is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Ganoderan polysaccharide pellet and preparation method thereof

InactiveCN101703532AGood dispersionQuick effectMetabolism disorderAntinoxious agentsBioavailabilityPharmaceutical Adjuvants
The invention provides a ganoderan polysaccharide pellet preparation, which is prepared from ganoderan polysaccharides and pharmaceutical adjuvants. The ganoderan polysaccharide pellet preparation is characterized in that: the pharmaceutical adjuvants are an excipient and a binding agent, wherein the pellet preparation comprises the following components in percentage by weight: 10 to 20 percent of ganoderan polysaccharides, 3 to 89 percent of excipient and 1 to 7 percent of bonding agent. The pellet preparation can be prepared into a slow-release or enteric-coated preparation as required. The ganoderan polysaccharide pellet preparation of the invention has high dissolving rate and high bioavailability. The method of the invention is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Compound lucid ganoderma extract pellets and preparation method thereof

InactiveCN104666367AGood dispersionQuick effectHydrocarbon active ingredientsGranular deliveryLycopersenePharmaceutical Adjuvants
The invention provides a compound lucid ganoderma extract pellet preparation. The pellet preparation is prepared from a lucid ganoderma extract, lycopene and pharmaceutical adjuvants and is characterized in that the pharmaceutical adjuvants include an excipient and an adhesive; the weight percentages of the lucid ganoderma extract, lycopene, excipient and adhesive in the pellet preparation are respectively 5-20%, 1-5%, 70-85% and 1-5%. The pellet preparation has high dissolution rate and bioavailability. A preparation method is simple and convenient and is easy to operate.
Owner:JF PHARMALAND TECH DEV

Lutein pellet and preparation method thereof

The invention provides a lutein pellet, which is prepared from lutein and a pharmaceutic adjuvant. The lutein pellet is characterized in that the pharmaceutic adjuvant is an excipient and an adhesive, wherein the pellet preparation contains 5-20% of lutein, 70-85% of excipient and 1-5% of adhesive. The lutein pellet disclosed by the invention is high in dissolution rate, and high in bioavailability, and the preparation method is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Collagen protein micro-pill and preparation method thereof

The invention provides a collagen pellet preparation, which is prepared from a collagen and a pharmaceutic adjuvant. The collagen pellet preparation is characterized in that the pharmaceutic adjuvant is an excipient and an adhesive; the weight percentage of the collagen in the pellet preparation is between 10 and 90 percent; the weight percentage of the excipient is between 20 and 80 percent; and the weight percentage of the adhesive is between 1 and 5 percent. The pellet preparation of the invention has the advantages of high dissolution rate, high bioavailability, simple and convenient preparation method, and easy operation.
Owner:JF PHARMALAND TECH DEV

Lycopene micropills and preparation thereof

The present invention provides a lycopene pellet preparation which is made from the lycopene and medical auxiliary materials and is characterized in that the medical auxiliary materials are excipient and bond. In the pellet preparation, the weight percentages of the materials are: 1 percent to 10 percent of the lycopene, 70 percent to 95 percent of the excipient and 1 percent to 5 percent of the bond. The pellet preparation of the present invention has high leaching rate and high biological utilization degree, and the preparation method is simple and convenient and is easy for operation.
Owner:JF PHARMALAND TECH DEV

Propolis pellets and preparation method thereof

InactiveCN104666355APropolis dispersionGood dispersionUnknown materialsGranular deliveryPharmaceutical AdjuvantsBioavailability
The invention provides a propolis pellet preparation. The pellet preparation is prepared from propolis and pharmaceutical adjuvants and is characterized in that the pharmaceutical adjuvants include an excipient and an adhesive; the weight percentages of the propolis, excipient and adhesive in the pellet preparation are respectively 5-20%, 70-85% and 1-5%. The pellet preparation has high dissolution rate and bioavailability. A preparation method is simple and convenient and is easy to operate.
Owner:JF PHARMALAND TECH DEV

Lemon peel pellet and preparation method thereof

InactiveCN105497220AGood dispersionQuick effectGranular deliveryFood preparationMedicineLemon peel extract
The invention provides a lemon peel extract pellet preparation. The lemon peel extract pellet preparation is prepared from lemon peel extract and pharmaceutical adjuvant and is characterized in that the pharmaceutical adjuvant is composed of an excipient and an adhesive and the weight percentages of the lemon peel extract, the excipient and the adhesive are 10 to 30%, 65 to 85% and 1 to 5%, respectively. The pellet preparation provided by the invention has a high dissolution rate and high bioavailability; and the preparation method for the pellet preparation is simple, convenient and easily practicable.
Owner:JF PHARMALAND TECH DEV

Hericium erinaceus micro-pills and preparation method thereof

The present invention provides hericium erinaceus micro-pill preparation, which is prepared from hericium erinaceus and pharmaceutical auxiliary materials, and is characterized in that the pharmaceutical auxiliary materials comprise an excipient and a binder, the hericium erinaceus content in the hericium erinaceus micro-pill preparation is 5-30 wt%, the excipient content in the hericium erinaceus micro-pill preparation is 65-85%, and the binder content in the hericium erinaceus micro-pill preparation is 1-5%. The hericium erinaceus micro-pill preparation of the present invention has characteristics of high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV

Compound mulberry extract product pellets and preparation method thereof

The invention provides compound mulberry extract product pellets, which can be prepared by an mulberry extract product, apple polyphenol and a pharmaceutic adjuvant. The compound mulberry extract product pellets are characterized in that the pharmaceutic adjuvant is an excipient and an adhesive, the weight percentage of the mulberry extract product in the compound mulberry extract product pellets accounts for 10-30%, the weight percentage of the apple polyphenol in the compound mulberry extract product pellets accounts for 5-10%, the weight percentage of the excipient accounts for 50-80%, and the weight percentage of the adhesive accounts for 5-10%. The compound mulberry extract product pellets have the advantages that leaching rate is high, bioavailability is high, preparation method is simple and convenient, and operation is easy.
Owner:JF PHARMALAND TECH DEV

Folium ginkgo extract micropill and preparation method thereof

The invention provides a preparation of a folium ginkgo extract micropill which is made of a folium ginkgo extract and medical accessories and is characterized in that the medical accessories comprise excipient and bond. The preparation of the folium ginkgo extract micropill is made of the following components by the weight percentage of 0.5-85 percent of folium ginkgo extract, 15-99.5 percent of excipient and 1-5 percent of bond. The preparation of the micropill has the advantages of high stripping rate and high bioavailability, and the preparation method is simple and convenient and can be operated easily.
Owner:JF PHARMALAND TECH DEV

Hawthorn flavone extract pellets and preparation method thereof

InactiveCN101703594AGood dispersionQuick effectGranular deliveryFood preparationAdjuvantPharmaceutical preservatives
The invention provides a hawthorn flavone extract pellet preparation, which is prepared from hawthorn flavone extract and medicinal adjuvant and is characterized in that the medicinal adjuvant comprises excipient and adhesive, wherein the hawthorn flavone extract in the pellet preparation accounts for 10 to 90 percent by weight, the excipient accounts for 5 to 89 percent by weight, and the adhesive accounts for 1 to 5 percent by weight. The pellet preparation can be prepared into a slow-release or enteric-coated preparation as requested. The hawthorn flavone extract pellet preparation has high dissolution rate and high bioavailability; and the method of the invention is simple, convenient and easy to operate.
Owner:JF PHARMALAND TECH DEV